Neoadjuvant chemotherapy with or without anthracyclines in the presence of dual HER2 blockade for HER2-positive breast cancer (TRAIN-2): a multicentre, open-label, randomised, phas... by van Ramshorst, Mette S, MD, van der Voort, Anna, MD, van Werkhoven, Erik D, MSc, Mandjes, Ingrid A, MSc, Kemper, Inge, MANP, Dezentjé, Vincent O, MD, Oving, Irma M, MD, Honkoop, Aafke H, MD, Tick, Lidwine W, MD, van de Wouw, Agnes J, MD, Mandigers, Caroline M, MD, van Warmerdam, Laurence J, MD, Wesseling, Jelle, Prof, Vrancken Peeters, Marie-Jeanne T, MD, Linn, Sabine C, Prof, Sonke, Gabe S, MD

Get full text

MRI-guided optimisation of neoadjuvant chemotherapy duration in stage II–III HER2-positive breast cancer (TRAIN-3): a multicentre, single-arm, phase 2 study by van der Voort, Anna, MD, Louis, Fleur M, MD, van Ramshorst, Mette S, MD, Kessels, Rob, PhD, Mandjes, Ingrid A, MSc, Kemper, Inge, MANP, Agterof, Mariette J, MD, van der Steeg, Wim A, MD, Heijns, Joan B, MD, van Bekkum, Marlies L, MD, Siemerink, Ester J, MD, Kuijer, Philomeen M, MD, Scholten, Astrid, MD, Wesseling, Jelle, Prof, Vrancken Peeters, Marie-Jeanne T F D, Prof, Mann, Ritse M, MD, Sonke, Gabe S, Prof

Get full text